Search research articles
Contact Us
Filters
Showing results (61-70 of 310) with videos related to
Page
of 31
Sort By:
JCO Oncology Practice
|
January 21, 2022
Health Literacy and Clinical Outcomes Following Hematopoietic Stem-Cell Transplantation
Natalie S Bezler, Maya Ilowite, Wendy B London, et al.
Cancer Medicine
|
December 16, 2024
Statistical Fragility of Findings From Randomized Phase 3 Trials in Pediatric Oncology
Hannah E Olsen, Pei-Chi Kao, Caleb Richmond, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
February 24, 2001
Ventricular enlargement in adults with profound mental retardation who demonstrate violent/destructive behaviors
P B May, K DeMarco, E B London, et al.
JCO Clinical Cancer Informatics
|
January 18, 2019
Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System
Arlene Naranjo, Meredith S Irwin, Michael D Hogarty, et al.
Clinical Pediatrics
|
November 19, 2021
Prevalence and Predictors of Iron Deficiency in Adolescent and Young Adult Outpatients: Implications for Screening
Rose Eiduson, Matthew M Heeney, Pei-Chi Kao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2008
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group
Jennifer Schneiderman, Wendy B London, Garrett M Brodeur, et al.
Journal of Pediatric Surgery
|
June 9, 2004
Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study
E Stanton Adkins, Robert Sawin, Robert B Gerbing, et al.
Journal of Pediatric Hematology/Oncology
|
July 11, 2006
Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: a report from the children's oncology group
Michal A Miller, Kensuke Ohashi, Xiaoyan Zhu, et al.
Pediatric Blood & Cancer
|
November 1, 2022
Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project
Kevin Campbell, Pei-Chi Kao, Arlene Naranjo, et al.
Pediatric Blood & Cancer
|
September 2, 2005
Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study
C K Tebbi, N Mendenhall, W B London, et al.
Page
of 31
Search research articles
Search
Showing results (61-70 of 310) with videos related to
Sort By:
Page
of 31
JCO Oncology Practice
|
January 21, 2022
Health Literacy and Clinical Outcomes Following Hematopoietic Stem-Cell Transplantation
Natalie S Bezler, Maya Ilowite, Wendy B London, et al.
Cancer Medicine
|
December 16, 2024
Statistical Fragility of Findings From Randomized Phase 3 Trials in Pediatric Oncology
Hannah E Olsen, Pei-Chi Kao, Caleb Richmond, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
February 24, 2001
Ventricular enlargement in adults with profound mental retardation who demonstrate violent/destructive behaviors
P B May, K DeMarco, E B London, et al.
JCO Clinical Cancer Informatics
|
January 18, 2019
Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System
Arlene Naranjo, Meredith S Irwin, Michael D Hogarty, et al.
Clinical Pediatrics
|
November 19, 2021
Prevalence and Predictors of Iron Deficiency in Adolescent and Young Adult Outpatients: Implications for Screening
Rose Eiduson, Matthew M Heeney, Pei-Chi Kao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2008
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group
Jennifer Schneiderman, Wendy B London, Garrett M Brodeur, et al.
Journal of Pediatric Surgery
|
June 9, 2004
Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study
E Stanton Adkins, Robert Sawin, Robert B Gerbing, et al.
Journal of Pediatric Hematology/Oncology
|
July 11, 2006
Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: a report from the children's oncology group
Michal A Miller, Kensuke Ohashi, Xiaoyan Zhu, et al.
Pediatric Blood & Cancer
|
November 1, 2022
Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project
Kevin Campbell, Pei-Chi Kao, Arlene Naranjo, et al.
Pediatric Blood & Cancer
|
September 2, 2005
Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study
C K Tebbi, N Mendenhall, W B London, et al.
Page
of 31